TIAA CREF Investment Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
2015
Q2
$57K Sell
2015
Q1
$208K Hold
2014
Q4
$215K Sell
2014
Q3
$325K Sell
2014
Q2
$914K Buy